Amanda Wooding
Directeur/Membre du Conseil chez 52 North Health Ltd.
Profil
Amanda Wooding is currently the Director at 52 North Health Ltd.
She is also the Deputy Head of Seed Funds at Cambridge Enterprise Ltd.
Dr. Wooding previously worked as the Director of Business Development at Acambis Plc, Director at Sphere Fluidics Ltd., and Principal at The Wellcome Trust Ltd.
She holds a doctorate degree from the University of Cambridge.
Postes actifs de Amanda Wooding
| Sociétés | Poste | Début |
|---|---|---|
Cambridge Enterprise Ltd.
 Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge. | Private Equity Investor | 01/01/2009 |
52 North Health Ltd.
 52 North Health Ltd. Information Technology ServicesTechnology Services 52 North Health Ltd. develops AI and medical-device based systems. The company is based in Cambridge, UK. The CEO of the British company is Umaima Malik Ahmad. | Directeur/Membre du Conseil | - |
Anciens postes connus de Amanda Wooding
| Sociétés | Poste | Fin |
|---|---|---|
The Wellcome Trust Ltd.
 The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Corporate Officer/Principal | - |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Corporate Officer/Principal | - |
Sphere Fluidics Ltd.
 Sphere Fluidics Ltd. BiotechnologyHealth Technology Sphere Fluidics Ltd. develops technology platform for single cell analysis and characterization. Its products include Picodroplet single cell assay and isolation system, Cyto-Mine, ESI-Mine, Pico-Break, Pico-Glide, Pico-Surf, and Pico-Gen Picodroplet formation chips. It provides technology and expertise for research projects, technology development collaborations, and discovery partnerships. The company was founded by Christopher Abell and Wilhelmus Theodorus Stefanus Huck in 2010 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - |
Formation de Amanda Wooding
| University of Cambridge | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Sphere Fluidics Ltd.
Sphere Fluidics Ltd. BiotechnologyHealth Technology Sphere Fluidics Ltd. develops technology platform for single cell analysis and characterization. Its products include Picodroplet single cell assay and isolation system, Cyto-Mine, ESI-Mine, Pico-Break, Pico-Glide, Pico-Surf, and Pico-Gen Picodroplet formation chips. It provides technology and expertise for research projects, technology development collaborations, and discovery partnerships. The company was founded by Christopher Abell and Wilhelmus Theodorus Stefanus Huck in 2010 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Miscellaneous |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
Cambridge Enterprise Ltd.
Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge. | Finance |
52 North Health Ltd.
52 North Health Ltd. Information Technology ServicesTechnology Services 52 North Health Ltd. develops AI and medical-device based systems. The company is based in Cambridge, UK. The CEO of the British company is Umaima Malik Ahmad. | Technology Services |